+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Allergy Immunotherapy Market: Global Industry Analysis (2015-2016) and Opportunity Assessment (2017-2025)

  • ID: 5116209
  • Report
  • March 2019
  • Region: Global
  • 191 pages
  • Future Market Insights

FEATURED COMPANIES

  • Aimmune Therapeutics
  • ALK-Abello A/S
  • Allergy Therapeutics
  • Anergis
  • Biomay AG
  • Circassia
  • MORE
A new report lends a holistic view of the global allergy immunotherapy market. This study provides an incisive look by analysing the restraints, opportunities, drivers, and pipeline products that could impact the growth of the allergy immunotherapy market. Market size has been analysed in the report in terms of revenue (US$ Mn). The allergy immunotherapy market has been studied by considering 2016 as the base year and the period 2017 to 2025 is the forecast period. This provides historical year-on-year growth data of the global allergy immunotherapy market.

The report analyses the existing as well as the future growth prospects of the allergy immunotherapy market. This will help the key stakeholders such as the manufacturers and distributors as well as the new entrants of the allergy immunotherapy market in devising sustainable strategies. The report commences with an executive summary to provide brief information about the market and its segmentation. Key trends and the recent development of the allergy immunotherapy market have been incorporated in this report, in order to help the stakeholders of the market.

Allergy Immunotherapy Market - Segmentation

This exclusive study assesses market attractiveness with the help of market segmentation. The allergy immunotherapy market has been bifurcated on the basis of region, distribution channel, treatment type and allergy type. Depending on the treatment type, allergy immunotherapy market has been segmented into sublingual immunotherapy & subcutaneous immunotherapy.

On the basis of the allergy type, the allergy immunotherapy market can be classified into asthma, allergic rhinitis, venom allergy, and food allergy, among others. Based on the distribution channel, the global allergy immunotherapy market has been fragmented into online pharmacies, retail pharmacies and drug stores, and hospital pharmacies.

Allergy Immunotherapy Market – Regional Analysis

Depending on the regions, the global allergy immunotherapy market can be classified into North America, the Middle East and Africa, Europe, Latin America, and Asia Pacific. The size and prediction for each of these regions have been incorporated in this report, along with their CAGRs for the forecasted period.

Significant countries in these regions that contribute to the growing size of the allergy immunotherapy market have also been assessed in this report. Qualitative analysis of the market has been carried out to provide information on the drivers, restraints, and opportunities prevailing in the global allergy immunotherapy market. The study also comprises of detailed analysis of market attractiveness for these regions.

Allergy Immunotherapy Market – Competition Analysis

Significant players operating in the allergy immunotherapy market comprise of Anergis, Biomay AG, Circassia, DBV Technologies, HAL Allergy Group, Merck KGaA, Allergy Therapeutics, ALK-Abello A/S, Aimmune Therapeutics, Stallergenes Greer, WOLW Pharma, Holister Stier, Allergopharma, and Leti, among others. The report encapsulates competitive scenario in order to help the stakeholders of the market understand the competition prevailing in the allergy immunotherapy market.

This market study includes a detailed overview of the companies, which provides valuable insights into the HQ, employee strength, and business segments. A detailed analysis of the product portfolio has been incorporated in this market study that provides details about the latest development in the allergy immunotherapy market.

The comprehensive study comprises of comprehensive SWOT analysis, which provides information on the key opportunities and challenges that could impact the growth of the global allergy immunotherapy market. In addition to this, the report incorporates strategic overview for each of the aforementioned firms, which helps understand the business strategies adopted by the market players. Financial overview of the significant companies of the allergy immunotherapy market has been included in this study, which will help the new entrants of the market understand the size and valuation of the companies.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aimmune Therapeutics
  • ALK-Abello A/S
  • Allergy Therapeutics
  • Anergis
  • Biomay AG
  • Circassia
  • MORE
Chapter 1 Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Chapter 2 Assumptions and Research Methodology

Chapter 3 Executive Summary: Global Allergy Immunotherapy Market

Chapter 4 Market Overview
4.1. Introduction
4.2. Key Industry Developments

Chapter 5 Market Dynamics
5.1. Drivers
5.2. Restraints
5.3. Opportunities
5.4. Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
5.5. Global Allergy Immunotherapy Market Outlook

Chapter 6 Global Allergy Immunotherapy Market Analysis and Forecast, by Treatment Type
6.1. Key Findings
6.2. Introduction
6.3. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
6.3.1. Subcutaneous Immunotherapy (SCIT)
6.3.2. Sublingual Immunotherapy(SLIT)
6.4. Market Attractiveness Analysis, by Treatment Type

Chapter 7 Global Allergy Immunotherapy Market Analysis and Forecast, by Allergy Type
7.1. Key Findings
7.2. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
7.2.1. Allergic Rhinitis
7.2.2. Asthma
7.2.3. Food Allergy
7.2.4. Venom Allergy
7.2.5. Others
7.3. Market Attractiveness Analysis, by Allergy Type
7.4. Key Trends

Chapter 8 Global Allergy Immunotherapy Market Analysis and Forecast, by Distribution Channel
8.1. Key Findings
8.2. Introduction
8.3. Market Size (US$ Mn) Forecast by Distribution Channel, 2017–2025
8.3.1. Hospital Pharmacy
8.3.2. Retail Pharmacy and Drug Stores
8.3.3. Online Pharmacy
8.4. Market Attractiveness Analysis, by Distribution Channel

Chapter 9 Global Allergy Immunotherapy Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Market Scenario
9.3. Market Value (US$ Mn) Forecast, by Region, 2017–2025
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Market Attractiveness Analysis, by Region

Chapter 10 North America Allergy Immunotherapy Market Analysis and Forecast
10.1. Key Findings
10.2. Market Size (US$ Mn) Forecast, by Country, 2017–2025
10.2.1. U.S.
10.2.2. Canada
10.3. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
10.3.1. SCIT
10.3.2. SLIT
10.4. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
10.4.1. Allergic Rhinitis
10.4.2. Asthma
10.4.3. Food Allergy
10.4.4. Venom Allergy
10.4.5. Other
10.5. Market Size (US$ Mn) Forecast by Distribution Channel, 2017–2025
10.5.1. Hospital Pharmacy
10.5.2. Retail Pharmacy and Drug Stores
10.5.3. Online Pharmacy
10.6. Market Attractiveness Analysis
10.6.1. By Country
10.6.2. By Treatment Type
10.6.3. By Allergy Type
10.6.4. By Distribution Channel

Chapter 11 Europe Allergy Immunotherapy Market Analysis and Forecast
11.1. Key Findings
11.2. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
11.2.1. Germany
11.2.2. U.K.
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
11.3.1. SCIT
11.3.2. SLIT
11.4. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
11.4.1. Allergic Rhinitis
11.4.2. Asthma
11.4.3. Food Allergy
11.4.4. Venom Allergy
11.4.5. Others
11.5. Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
11.5.1. Hospital Pharmacy
11.5.2. Retail Pharmacy and Drug Stores
11.5.3. Online Pharmacy
11.6. Market Attractiveness Analysis
11.6.1. By Country
11.6.2. By Treatment Type
11.6.3. By Allergy Type
11.6.4. By Distribution Channel

Chapter 12 Asia Pacific Allergy Immunotherapy Market Analysis and Forecast
12.1. Key Findings / Developments
12.2. Market Overview
12.3. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
12.3.1. China
12.3.2. India
12.3.3. Japan
12.3.4. Australia & New Zealand
12.3.5. Rest of Asia Pacific
12.4. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
12.4.1. SCIT
12.4.2. SLIT
12.5. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
12.5.1. Allergic Rhinitis
12.5.2. Asthma
12.5.3. Food Allergy
12.5.4. Venom Allergy
12.5.5. Others
12.6. Market Size (US$ Mn) Forecast by Distribution Channel, 2017–2025
12.6.1. Hospital Pharmacy
12.6.2. Retail Pharmacy and Drug Stores
12.6.3. Online Pharmacy
12.7. Market Attractiveness Analysis
12.7.1. By Country
12.7.2. By Treatment Type
12.7.3. By Allergy Type
12.7.4. By Distribution Channel

Chapter 13 Latin America Allergy Immunotherapy Market Analysis and Forecast
13.1. Key Findings / Developments
13.2. Market Overview
13.3. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
13.3.1. Brazil
13.3.2. Mexico
13.3.3. Rest of Latin America
13.4. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
13.4.1. SCIT
13.4.2. SLIT
13.5. Market Size (US$ Mn) Forecast, by Allergy Type, 2017-2025
13.5.1. Allergic Rhinitis
13.5.2. Asthma
13.5.3. Food Allergy
13.5.4. Venom Allergy
13.5.5. Others
13.6. Market Size (US$ Mn) Forecast by Distribution Channel, 2017–2025
13.6.1. Hospital Pharmacy
13.6.2. Retail Pharmacy and Drug Stores
13.6.3. Online Pharmacy
13.7. Market Attractiveness Analysis
13.7.1. By Country/Sub-region
13.7.2. By Treatment Type
13.7.3. By Allergy Type
13.7.4. By Distribution Channel

Chapter 14 Middle East & Africa Allergy Immunotherapy Market Analysis and Forecast
14.1. Key Findings / Developments
14.2. Market Overview
14.3. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
14.3.1. GCC Countries
14.3.2. South Africa
14.3.3. Israel
14.3.4. Rest of Middle East & Africa
14.4. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
14.4.1. SCIT
14.4.2. SLIT
14.5. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
14.5.1. Allergic Rhinitis
14.5.2. Asthma
14.5.3. Food Allergy
14.5.4. Venom Allergy
14.5.5. Others
14.6. Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
14.6.1. Hospital Pharmacy
14.6.2. Retail Pharmacy and Drug Stores
14.6.3. Online Pharmacy
14.7. Market Attractiveness Analysis
14.7.1. By Country/Sub-region
14.7.2. By Treatment Type
14.7.3. By Allergy Type
14.7.4. By Distribution Channel

Chapter 15 Pipeline Analysis
15.1.1. Allergy Immunotherapy Pipeline Analysis (2017)

Chapter 16 Allergy Immunotherapy – Regulatory Overview
16.1.1. Regulatory Status for European Union
16.1.2. Regulatory Status for U.S.

Chapter 17 Competition Landscape
17.1. Global Allergy Immunotherapy Market Share, by Company, 2017
17.2. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
17.2.1. ALK-Abello A/S
17.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.1.2. Product Portfolio
17.2.1.3. SWOT Analysis
17.2.1.4. Strategic Overview
17.2.2. Allergy Therapeutics
17.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.2.2. Product Portfolio
17.2.2.3. SWOT Analysis
17.2.2.4. Strategic Overview
17.2.3. Stallergenes Greer
17.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.3.2. Product Portfolio
17.2.3.3. SWOT Analysis
17.2.3.4. Financial Overview
17.2.3.5. Strategic Overview
17.2.4. HAL Allergy Group
17.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.4.2. Product Portfolio
17.2.4.3. SWOT Analysis
17.2.4.4. Financial Overview
17.2.4.5. Strategic Overview
17.2.5. DBV Technologies
17.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.5.2. Product Portfolio
17.2.5.3. SWOT Analysis
17.2.5.4. Financial Overview
17.2.5.5. Strategic Overview
17.2.6. Merck KGaA
17.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.6.2. Product Portfolio
17.2.6.3. SWOT Analysis
17.2.6.4. Financial Overview
17.2.6.5. Strategic Overview
17.2.7. Aimmune Therapeutics
17.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.7.2. Product Portfolio
17.2.7.3. SWOT Analysis
17.2.7.4. Financial Overview
17.2.7.5. Strategic Overview
17.2.8. Circassia
17.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.8.2. Product Portfolio
17.2.8.3. SWOT Analysis
17.2.8.4. Financial Overview
17.2.8.5. Strategic Overview
17.2.9. Anergis
17.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.9.2. Product Portfolio
17.2.9.3. SWOT Analysis
17.2.9.4. Financial Overview
17.2.9.5. Strategic Overview
17.2.10. Biomay AG
17.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.10.2. Product Portfolio
17.2.10.3. SWOT Analysis
17.2.10.4. Financial Overview
17.2.10.5. Strategic Overview
Note: Product cover images may vary from those shown
  • ALK-Abello A/S
  • Allergy Therapeutics
  • Stallergenes Greer
  • HAL Allergy Group
  • DBV Technologies
  • Merck KGaA
  • Aimmune Therapeutics
  • Circassia
  • Anergis
  • Biomay AG
Note: Product cover images may vary from those shown
Adroll
adroll